TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.0100nM ΔG°: -65.3kJ/molepH: 5.5 T: 2°CAssay Description:Inhibition of HIV protease was measured by assay of the cleavage of a fluorescent peptide substrate. The fluorescent product (2-aminobenzoyl-Ala-Thr-...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.0100nMAssay Description:Inhibition constant of HIV protease inhibitorsMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.0200nMAssay Description:Inhibition constant of HIV protease inhibitorsMore data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.0200nM ΔG°: -63.5kJ/molepH: 5.5 T: 2°CAssay Description:Inhibition of HIV protease was measured by assay of the cleavage of a fluorescent peptide substrate. The fluorescent product (2-aminobenzoyl-Ala-Thr-...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.0200nMAssay Description:Inhibition constant of HIV protease inhibitorsMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.0200nMAssay Description:Inhibition constant of HIV protease inhibitorsMore data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.0200nMAssay Description:Inhibition of HIV protease was measured by assay of the cleavage of a fluorescent peptide substrate. The fluorescent product (2-aminobenzoyl-Ala-Thr-...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.0200nMAssay Description:Inhibition constant of HIV protease inhibitorsMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.0270nMAssay Description:Inhibition constant of HIV protease inhibitorsMore data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.0300nM ΔG°: -62.5kJ/molepH: 5.5 T: 2°CAssay Description:Inhibition of HIV protease was measured by assay of the cleavage of a fluorescent peptide substrate. The fluorescent product (2-aminobenzoyl-Ala-Thr-...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.0300nMAssay Description:Inhibition constant of HIV protease inhibitorsMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.0300nMAssay Description:Inhibition constant of HIV protease inhibitorsMore data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.0300nM ΔG°: -62.5kJ/molepH: 5.5 T: 2°CAssay Description:Inhibition of HIV protease was measured by assay of the cleavage of a fluorescent peptide substrate. The fluorescent product (2-aminobenzoyl-Ala-Thr-...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.0600nMAssay Description:Inhibition of HIV protease was measured by assay of the cleavage of a fluorescent peptide substrate. The fluorescent product (2-aminobenzoyl-Ala-Thr-...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.0600nMAssay Description:Inhibition constant of HIV protease inhibitorsMore data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.0600nM ΔG°: -60.7kJ/molepH: 5.5 T: 2°CAssay Description:Inhibition of HIV protease was measured by assay of the cleavage of a fluorescent peptide substrate. The fluorescent product (2-aminobenzoyl-Ala-Thr-...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.0600nMAssay Description:Inhibition constant of HIV protease inhibitorsMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.0600nMAssay Description:Inhibition constant of HIV protease inhibitorsMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.0600nMAssay Description:Inhibition constant of HIV protease inhibitorsMore data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.0600nM ΔG°: -60.7kJ/molepH: 5.5 T: 2°CAssay Description:Inhibition of HIV protease was measured by assay of the cleavage of a fluorescent peptide substrate. The fluorescent product (2-aminobenzoyl-Ala-Thr-...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.0800nMAssay Description:Inhibition of HIV protease was measured by assay of the cleavage of a fluorescent peptide substrate. The fluorescent product (2-aminobenzoyl-Ala-Thr-...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.0800nM ΔG°: -59.9kJ/molepH: 5.5 T: 2°CAssay Description:Inhibition of HIV protease was measured by assay of the cleavage of a fluorescent peptide substrate. The fluorescent product (2-aminobenzoyl-Ala-Thr-...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.0800nMAssay Description:Inhibition constant of HIV protease inhibitorsMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.0800nMAssay Description:Inhibition constant of HIV protease inhibitorsMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.0900nMAssay Description:Inhibition constant of HIV protease inhibitorsMore data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.100nM ΔG°: -59.4kJ/molepH: 5.5 T: 2°CAssay Description:Inhibition of HIV protease was measured by assay of the cleavage of a fluorescent peptide substrate. The fluorescent product (2-aminobenzoyl-Ala-Thr-...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.100nMAssay Description:Inhibition of HIV protease was measured by assay of the cleavage of a fluorescent peptide substrate. The fluorescent product (2-aminobenzoyl-Ala-Thr-...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.100nMAssay Description:Inhibition constant of HIV protease inhibitorsMore data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.100nM ΔG°: -59.4kJ/molepH: 5.5 T: 2°CAssay Description:Inhibition of HIV protease was measured by assay of the cleavage of a fluorescent peptide substrate. The fluorescent product (2-aminobenzoyl-Ala-Thr-...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.100nMAssay Description:Inhibition constant of HIV protease inhibitorsMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.100nMAssay Description:Inhibition constant of HIV protease inhibitorsMore data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.100nMAssay Description:Inhibition of HIV protease was measured by assay of the cleavage of a fluorescent peptide substrate. The fluorescent product (2-aminobenzoyl-Ala-Thr-...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.100nMAssay Description:Inhibition constant of HIV protease inhibitorsMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.120nMAssay Description:Inhibition constant of HIV protease inhibitorsMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.130nMAssay Description:Inhibition constant of HIV protease inhibitorsMore data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.130nMAssay Description:Inhibition of HIV protease was measured by assay of the cleavage of a fluorescent peptide substrate. The fluorescent product (2-aminobenzoyl-Ala-Thr-...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.140nMAssay Description:Inhibition constant of HIV protease inhibitorsMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.140nMAssay Description:Inhibition constant of HIV protease inhibitorsMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.150nMAssay Description:Inhibition constant of HIV protease inhibitorsMore data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.150nM ΔG°: -58.3kJ/molepH: 5.5 T: 2°CAssay Description:Inhibition of HIV protease was measured by assay of the cleavage of a fluorescent peptide substrate. The fluorescent product (2-aminobenzoyl-Ala-Thr-...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.240nMAssay Description:Inhibition constant of HIV protease inhibitorsMore data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.240nMAssay Description:Inhibition of HIV protease was measured by assay of the cleavage of a fluorescent peptide substrate. The fluorescent product (2-aminobenzoyl-Ala-Thr-...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.25nMAssay Description:Inhibition constant of HIV protease inhibitorsMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.280nMAssay Description:Inhibition constant of HIV protease inhibitorsMore data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.280nMAssay Description:Inhibition of HIV protease was measured by assay of the cleavage of a fluorescent peptide substrate. The fluorescent product (2-aminobenzoyl-Ala-Thr-...More data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.280nMAssay Description:Inhibition constant of HIV protease inhibitorsMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.300nMAssay Description:Inhibition constant of HIV protease inhibitorsMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.310nMAssay Description:Inhibition constant of HIV protease inhibitorsMore data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.310nM ΔG°: -56.5kJ/molepH: 5.5 T: 2°CAssay Description:Inhibition of HIV protease was measured by assay of the cleavage of a fluorescent peptide substrate. The fluorescent product (2-aminobenzoyl-Ala-Thr-...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
DuPont Pharmaceuticals Company
DuPont Pharmaceuticals Company
Affinity DataKi: 0.380nMAssay Description:Inhibition of HIV protease was measured by assay of the cleavage of a fluorescent peptide substrate. The fluorescent product (2-aminobenzoyl-Ala-Thr-...More data for this Ligand-Target Pair